Abstract:
A multi-directional remote control system and method is adapted for use with an entertainment system of a type including a display such as a monitor or TV and having display functions employing a mouse type control. The remote controller may be conveniently held in one hand of a user and still provides full mouse type functionality. The remote control system and method images the controller to detect relative motion between the controller and screen. This position information is used for control of a cursor or other GUI interface with automatic control of cursor speed based on detected controller distance from the screen and characteristic hand movement.
Abstract:
A multi-directional remote control system and method is adapted for use with an entertainment system of a type including a display such as a monitor or TV and having display functions employing a mouse type control. The remote controller may be conveniently held in one hand of a user and still provides full mouse type functionality. The remote control system and method images the controller to detect relative motion between the controller and screen. This position information is used for control of a cursor or other GUI interface with automatic control of cursor speed based on detected controller distance from the screen and characteristic hand movement.
Abstract:
A plurality of application services are provided to subscriber devices in a cloud computing network. A plurality of requests for application services are received from a subscriber device via a customized private network connection assigned to the subscriber device, and the requests for application services are aggregated with requests for application services from other subscriber devices. The requests are transmitted to application servers within the cloud computing network hosting applications for performing the application services. The subscriber device is provided with the requested plurality of application services via the customized private network connection.
Abstract:
Amine compounds, amine polymers, crosslinked amine polymers and pharmaceutical compositions comprising the same may include polyhydroxy-containing cores that may be substituted with amine groups and may be used to treat hyperphosphatemia or to remove ions from the gastrointestinal tract of animals, including humans.
Abstract:
A gate valve includes a pair of opposing housing members, a gate, primary sealing sleeves and a secondary sealing member. The primary sealing sleeves are disposed in each of the housing members. The gate is configured to slidably pass through a transverse gate chamber defined when the housing members are joined together. The secondary sealing member is secured between the housing members and includes at least one passage or aperture configured to allow lubricating fluid to be applied through at least one of the housing members through the secondary sealing member and onto the gate.
Abstract:
Disclosed herein is a nanostructured material comprising defective carbon nanotubes chosen from impregnated, functionalized, doped, charged, coated, and irradiated nanotubes, and combinations thereof. The defective carbon nanotubes contain a defect which is a lattice distortion in at least one carbon ring. Also disclosed is a method of purifying fluids, such as liquids, including water, as well as gases, including the air using, this nanostructured material.
Abstract:
The invention provides compounds of formula 1 wherein R1, R2, R3, and R4 are as defined, and their pharmaceutically acceptable salts. Compounds of formula 1 are indicated to have activity inhibiting cdk5, cdk2, and GSK-3. Pharmaceutical compositions and methods comprising compounds of formula 1 for treating and preventing diseases and conditions comprising abnormal cell growth, such as cancer, and neurodegenerative diseases and conditions and those affected by dopamine neurotransmission. Also described are pharmaceutical compositions and methods comprising compounds of formula 1 for treating male fertility and sperm motility; diabetes mellitus; impaired glucose tolerance; metabolic syndrome or syndrome X; polycystic ovary syndrome; adipogenesis and obesity; myogenesis and frailty, for example age-related decline in physical performance; acute sarcopenia, for example muscle atrophy and/or cachexia associated with burns, bed rest, limb immobilization, or major thoracic, abdominal, and/or orthopedic surgery; sepsis; hair loss, hair thinning, and balding; and immunodeficiency.
Abstract:
Disclosed herein are articles for removing contaminants from a fluid, such as a liquid or gas, the article comprising carbon nanotubes, which comprise at least one molecule or cluster attached thereto or located therein, wherein the carbon nanotubes are present in the article in an amount sufficient to reduce the concentration of contaminants in fluid that come into contact with the article. A method of making the nanomesh material used in such articles is also disclosed, as are methods of purifying fluids using these articles.
Abstract:
A cutoff saw assembly incorporates a robot assembly with a compliant cutting apparatus to remove various undesired metal extensions from a casting. The assembly cooperatively and conjunctively controls the position of the casting using the robot assembly and the force exerted by the cutting apparatus on the casting using a compliance control system. The compliance control system includes a compliance actuator that is connected to a compliance regulator. Both the robot assembly and the compliance control system are connected to a system controller. The compliance actuator is connected to the cutoff blade to actively vary the force of the cutting blade with respect to the casting. The compliance regulator, which is connected to the system controller, will measure and regulate the pressure in the compliance actuator, such that the robot assembly and compliance control system can apply the required force to cut the casting.
Abstract:
Trisubstituted heteroaromatic compounds having the structure are provided, wherein X is C or N; A and B are each independently CH or N, with the proviso that A and B cannot both be CH; R1 is Ar-L-; R2 is hydrogen or alkyl; or R1 and R2 can be joined together to form a 4- to 7-membered cycloheteroalkyl ring; R3 to R8, Ar and L are as defined herein. A method for using these compounds to treat diseases associated with abnormal bone or mineral homeostasis is also provided.
Abstract translation:提供具有该结构的三取代杂芳族化合物,其中X为C或N; A和B各自独立地为CH或N,条件是A和B不能都是CH; R 1是Ar-L-; R 2是氢或烷基; 或R 1和R 2可以连接在一起形成4-至7-元环杂烷基环; R 3至R 8中,Ar和L如本文所定义。 还提供了使用这些化合物治疗与异常骨或矿物质内稳态相关疾病的方法。